Medication for Graves’ Disease in Children | oneGRAVESvoice
Global Search
Global Search

Trusted Resources: Evidence & Education

Scientific literature and patient education texts

Back to Evidence & Education / Patient Education

Medication for Graves’ Disease in Children

key information

source: NYU Langone Hospitals

year: N/A

summary/abstract:

Doctors at Hassenfeld Children’s Hospital at NYU Langone prescribe medications to treat children with Graves’ disease, an autoimmune disorder. That means the immune system attacks the thyroid and makes it produce too much thyroid hormone. Our doctors often recommend medication to decrease the production of these hormones and to diminish their effects on the body.

Doctors may prescribe an antithyroid medication called methimazole to slow the production of thyroid hormones. Methimazole is often effective in children who have mild symptoms of Graves’ disease. Your child takes this medication daily, by mouth.

Your child may begin to notice improvements in symptoms, such as reduced eye irritation, weight gain, and less sensitivity to temperature, after taking antithyroid medication for several weeks. Antithyroid therapy may be continued for several months, until the immune system reaction that triggered the condition subsides.

read more

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Powered by

Brought to you by

Supported through an independent
educational grant by

© 2022 rareLife solutions Inc.